Home 
Headlines July, 2008 Gold nanoparticle cancer treatment 'could be trialled on humans'
Headlines July, 2008 Gold nanoparticle cancer treatment 'could be trialled on humans'
Gold nanoparticle cancer treatment 'could be trialled on humans'
Thursday 31st 2008f July, 2008
A new cancer treatment process that uses gold nanoparticles could enter the human trial phase by 2010, it has emerged.
Developed by John Kanzius and researchers in Texas, the process spikes cancer cells with gold nanoparticles and heats them in a non-invasive way to fatal frequencies from the Kanzius RF Generator, reports the Pittsburgh Post-Gazette.
Mr Kanzius hails from Erie, Pennsylvania and his pioneering developed has been welcomed by political figures in the state.
Governor Ed Rendell and US senators Arlen Specter and Bob Casey are reportedly working to secure funding for the research.
Dr Steven Curley of the MD Anderson Cancer Centre in Houston told the publication: "We've proven we can get nanoparticles inside to kill cancer cells.
"We can target these cancer cells."
The MD Anderson Cancer Centre has existed since 1941, working to eliminate cancer through integrated programmes in treatment, clinical trials, educational programmes and prevention.
Developed by John Kanzius and researchers in Texas, the process spikes cancer cells with gold nanoparticles and heats them in a non-invasive way to fatal frequencies from the Kanzius RF Generator, reports the Pittsburgh Post-Gazette.
Mr Kanzius hails from Erie, Pennsylvania and his pioneering developed has been welcomed by political figures in the state.
Governor Ed Rendell and US senators Arlen Specter and Bob Casey are reportedly working to secure funding for the research.
Dr Steven Curley of the MD Anderson Cancer Centre in Houston told the publication: "We've proven we can get nanoparticles inside to kill cancer cells.
"We can target these cancer cells."
The MD Anderson Cancer Centre has existed since 1941, working to eliminate cancer through integrated programmes in treatment, clinical trials, educational programmes and prevention.
© Adfero Limited
